Bridging the gap between research and commercial reality is one of the biggest challenges in innovation. Enabling scientists to turn research into real-world impact is made possible through the North East Scotland ICURe Discover – a programme designed to equip researchers with the tools, insight and environment they need to succeed, supported by the collaborative life sciences ecosystem and community at ONE BioHub.

In an episode of Base to Base Biotech, produced by Deep Tech Digest, attention is turned to the growing life sciences ecosystem in Aberdeen and the role of ONE BioHub in supporting innovation with global impact.

The strength and ambition of North East Scotland’s life sciences community was demonstrated at this year’s Scottish EDGE Awards, with several early-stage companies from the region – Brigid Bio, mycoBiologics, CAnswer BioSolutions, Formartine Bio and ZygoteLink – securing recognition.

Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions, today announced that it has opened a new state-of-the-art clinical research centre at ONE BioHub, Aberdeen.

EpitogenX aims to revolutionise diagnostics through innovative technology and deep collaboration with academic and clinical partners.

Deborah O’Neil, chair of the ONE Life Sciences and BioAberdeen responds to the Sunday Times’ article. Last week, think tank Our Scottish Future published a report – “Innovation Nation: Good Jobs for Scotland’s Future”. It was positioned as a Scottish industrial strategy, anchored by innovation-led growth and identified life sciences as a sectoral strength for Scotland. If Scotland is serious about building the future economy, it needs to look north.

Through strong leadership, customer-centric growth, and a long-term vision for R&D, NCIMB is poised to deliver microbial solutions that address some of society’s biggest challenges—from decarbonisation to healthy living.